Bellevue Group AG - GENMARK DIAGNOSTICS INC ownership

GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 99 filers reported holding GENMARK DIAGNOSTICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Bellevue Group AG ownership history of GENMARK DIAGNOSTICS INC
ValueSharesWeighting
Q4 2020$38,057,000
+112.1%
2,606,636
+106.3%
0.44%
+75.8%
Q3 2020$17,946,000
-18.1%
1,263,811
-15.1%
0.25%
-20.0%
Q2 2020$21,907,000
+120.5%
1,489,284
-38.3%
0.31%
+60.6%
Q1 2020$9,937,000
-15.4%
2,411,926
-1.2%
0.19%
+3.8%
Q4 2019$11,742,000
-14.5%
2,441,241
+7.7%
0.19%
-27.3%
Q3 2019$13,740,000
-10.0%
2,267,252
-3.6%
0.26%
-1.9%
Q2 2019$15,271,000
-8.5%
2,353,0670.0%0.26%
-71.6%
Q1 2019$16,683,000
+71.7%
2,353,067
+17.7%
0.92%
+43.7%
Q4 2018$9,718,000
-1.3%
1,999,540
+49.3%
0.64%
+2.2%
Q3 2018$9,845,000
+30.1%
1,339,502
+12.9%
0.62%
-3.1%
Q2 2018$7,570,000
+17.3%
1,186,5020.0%0.64%
+0.8%
Q1 2018$6,455,000
+100.1%
1,186,502
+53.4%
0.64%
+89.9%
Q4 2017$3,226,000
-36.0%
773,677
+47.7%
0.34%
-36.1%
Q3 2017$5,043,000
+5.2%
523,677
+29.2%
0.53%
-7.1%
Q2 2017$4,793,000
+19.6%
405,178
+29.6%
0.57%
+6.2%
Q1 2017$4,008,000312,6660.53%
Other shareholders
GENMARK DIAGNOSTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Versor Investments LP 2,664,831$63,689,0003.80%
Chicago Capital Management, LLC 318,113$7,603,0003.54%
First Trust Capital Management L.P. 564,758$13,498,0002.64%
WATER ISLAND CAPITAL LLC 1,693,162$40,467,0002.47%
Sand Grove Capital Management LLP 992,068$23,710,0002.31%
EMC Capital Management 121,023$2,892,0002.06%
OMNI PARTNERS LLP 1,540,671$36,822,0001.82%
TIG Advisors, LLC 1,774,849$42,419,0001.60%
Cowen Prime Services LLC 174,850$4,179,0001.58%
G2 Investment Partners Management LLC 396,400$9,474,0001.50%
View complete list of GENMARK DIAGNOSTICS INC shareholders